<SEC-DOCUMENT>0001172661-25-003249-index.html : 20250814
<SEC-HEADER>0001172661-25-003249.hdr.sgml : 20250814
<ACCEPTANCE-DATETIME>20250814080103
ACCESSION NUMBER:		0001172661-25-003249
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250814
DATE AS OF CHANGE:		20250814

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Enliven Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001672619
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				811523849
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-91465
		FILM NUMBER:		251214450

	BUSINESS ADDRESS:	
		STREET 1:		6200 LOOKOUT ROAD
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301
		BUSINESS PHONE:		720-647-8519

	MAIL ADDRESS:	
		STREET 1:		6200 LOOKOUT ROAD
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IMARA Inc.
		DATE OF NAME CHANGE:	20160419

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Polar Capital Holdings Plc
		CENTRAL INDEX KEY:			0001837309
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	BUSINESS ADDRESS:	
		STREET 1:		16 PALACE STREET
		CITY:			LONDON
		STATE:			X0
		ZIP:			SW1E 5JD
		BUSINESS PHONE:		02072272700

	MAIL ADDRESS:	
		STREET 1:		16 PALACE STREET
		CITY:			LONDON
		STATE:			X0
		ZIP:			SW1E 5JD
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>